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Abstract
Background: Research on quality and satisfaction with care during palliative chemotherapy in oncology
patients has been limited. The objective was to assess the association between patient's satisfaction with
care and symptom severity and to evaluate test-retest of a satisfaction survey in this study population.
Methods:  A prospective cohort of patients with recurrent gynecologic malignancies receiving
chemotherapy were enrolled after a diagnosis of recurrent cancer. Patients completed the Quality of End-
of-Life care and satisfaction with treatment scale (QUEST) once upon enrollment in an outpatient setting
and again a week later. Patients also completed the Mini-Mental Status Exam, the Hospital Anxiety/
Depression Scale, a symptom severity scale and a demographic survey. Student's t-test, correlation
statistics and percent agreement were used for analysis.
Results: Data from 39 patients were analyzed. Mean (SD) quality of care summary score was 41.95 (2.75)
for physicians and 42.23 (5.42) for nurses (maximum score was 45; p = 0.76 for difference in score
between providers). Mean (SD) satisfaction of care summary score was 29.03 (1.92) for physicians and
29.28 (1.70) for nurses (maximum score was 30; p = 0.49 for difference between providers). Test-retest
for 33 patients who completed both QUEST surveys had high percent agreement (74–100%), with the
exception of the question regarding the provider arriving late (45 and 53%). There was no correlation
between quality and satisfaction of care and symptom severity. Weakness was the most common symptom
reported. Symptom severity correlated with depression (r = 0.577 p < 0.01). There was a trend towards
a larger proportion of patients reporting pain who had three or more prior chemotherapy regimens (p =
0.075). Prior number of chemotherapy regimens or time since diagnosis was not correlated with symptom
severity score. Anxiety and depression were correlated with each other (r = 0.711, p < 0.01). There was
no difference in symptom severity score at enrollment between those patients who have since died (n =
19) versus those who are still alive.
Conclusion: The QUEST Survey has test-retest reliability when used as a written instrument in an
outpatient setting. However, there was no correlation between this measure and symptom severity.
Patient evaluation of care may be more closely related to the interpersonal aspects of the health care
provider relationship than it is to physical symptoms.
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Background
Understanding patient perceptions of technical and inter-
personal care they receive and satisfaction with that care is
essential. Assessments of quality and satisfaction of care in
oncology have focused on patients' satisfaction with phy-
sicians or the health care system [1,2]. Research on satis-
faction during palliative care and care at the end of life
(EoL) of cancer patients has been limited [3]. Global
measures of quality and satisfaction with care are not
completely revealing, because they do not indicate on
which issues, such as symptom management, the provider
should focus on improving [4].
Patients' satisfaction with care may be significantly
affected by their symptoms and the physician's response
to these symptoms, particularly during the advanced
stages of cancer. Gynecologic cancer symptoms are multi-
factorial in character as the primary cancer frequently
metastasizes to other pelvic and abdominal organs.
Women with ovarian cancer present with a constellation
of symptoms including back pain, fatigue, abdominal
pain and urinary symptoms [5]. Ferrell et al assessed
patients with ovarian cancer post-diagnosis; pain, fatigue
and gastrointestinal effects were the most problematic [6].
Sun et al revealed that fatigue was a significant problem
including higher levels of distress in ovarian cancer
patients with recurrent disease [7]. However, the extent to
which satisfaction with care is related to perceptions of
concern and efforts by providers or to underlying patient
mood state, not just to symptoms, is not known [8].
The purpose of this study was to examine the relationship
between patients' perception of quality and satisfaction
with care and symptom severity during palliative chemo-
therapy for recurrent gynecologic malignancies. In 2004,
the National Cancer Institute declared the importance of
improving symptom management for cancer patients [9].
However, there is currently no information on the link
between this population's symptoms, anxiety, depression
and perception of the quality of cancer care directly influ-
enced by clinicians. In addition, we wanted to evaluate the
test-retest properties of the Quality of End-of-Life care and
satisfaction with treatment scale (QUEST) Survey in this
study population.
Methods
Prospective patients with gynecologic malignancies
receiving chemotherapy were enrolled after a diagnosis of
recurrent cancer in this IRB approved study. Patients were
seen in the oncology clinic office by their treating gyneco-
logic oncologist and chemotherapy nurse specialist and
informed consent was obtained for participation in this
study. Patients received a variety of chemotherapy agents
depending on prior treatment and patient/physician pref-
erences. Eligibility criteria included age of 18 or greater
and a mini-mental status exam score of 12 or higher.
Patients completed the QUEST survey regarding quality of
care and satisfaction with care received from both their
physicians and nurses. The survey was completed once
upon enrollment in an outpatient setting and again a
week later. Patient responses were placed in a sealed enve-
lope and they were assured that their individual responses
would not be revealed to their treating physician or nurse.
Patients also completed the Mini-Mental Status Exam, the
Hospital Anxiety/Depression, a symptom severity scale
and a demographic survey. Patient charts were reviewed to
obtain demographic and clinical variables.
Measures
The QUEST Survey contains fifteen items categorized into
two sub-scales in which patient's rate the quality of the
care they have received from their physicians and nurses
separately, and their satisfaction with care. Quality (nine
questions) was rated using a 5-point Likert scale to assess
how often particular behaviors or styles of care were true
of their health care providers. Ratings ranged from never
to always. Similarly, satisfaction (six questions) was rated
using a 5-point Likert scale ranging from "very dissatis-
fied" to "very satisfied". Items for each scale were sum-
mated to obtain an overall score for both quality and
satisfaction with care [3].
Folstein et al developed a simplified, scored form to eval-
uate mental state. The Mini-mental status exam (MMSE)
includes eleven questions (maximum score of 30),
requires 5–10 minutes to administer and is practical for
use serially and routinely. The MMS concentrates on the
cognitive aspects of mental functions and has docu-
mented validity and reliability [10]. This evaluation tool
was used to screen patients at enrollment for any mental
deficiencies. In addition this tool has not been used
before in this patient population. The Hospital Anxiety
and Depression Scale (HAD) has been established as a
convenient self-rating screening instrument for anxiety
and depression [11,12]. The survey consists of fourteen
multiple choice items that are scored on a scale of 0 to 3
and questions are categorized as measuring anxiety versus
depression accordingly. A score of 8 or higher on either
scale indicates the possibility that the patient may have an
anxiety or depression disorder and should be evaluated
further. Previous research in this population has indicated
increased levels of anxiety/depression [7].
A symptom severity scale adapted from that of Mer-
cadante et al was used to analyze frequency and severity of
common gynecologic cancer symptoms [13]. Symptoms
included pain, shortness of breath, nausea/vomiting,
weakness and drowsiness and were included in a standard
form and rated for severity (absent 0, mild 1, moderate 2,
severe 3). A brief demographic survey regarding religiousHealth and Quality of Life Outcomes 2006, 4:84 http://www.hqlo.com/content/4/1/84
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affiliation and educational level was completed by
patients.
Statistical analysis
Patient demographics and clinical characteristics were
summarized using descriptive statistics. Student's t-test
was used to compare QUEST scores between physicians
(MD) and nurses (RN) in all patients and correlation
analysis was done between the HADS, symptom severity
scale and QUEST surveys in order to determine if
increased symptoms were association with increased
depression or anxiety and decreased satisfaction score.
Patients completing both QUEST surveys (n = 33) were
used to compare scores between the initial survey and a
second survey administered one week later. Percent agree-
ment, correlations, and paired t-tests were used to com-
pare scores for patients completing the survey at both time
points. Symptom severity was analyzed in only ovarian
cancer patients by correlation analysis and chi-square sta-
tistics. The other gynecologic malignancies were not
included in this analysis as the number of cases were small
and interpretation may not be applicable to other cancer
types.
Results
Forty-four patients were approached regarding the study
and 41 enrolled in this prospective study from September
2003 – March 2006. Two patients after enrollment refused
to continue due to time constraints. Patient demographics
and clinical characteristics of 39 patients with complete
data are summarized in Table 1. The majority of patients
were married, Caucasian and had some college or higher
education (57%). Gynecologic cancers included 79%
ovarian cancer, 18% endometrial cancer and 2.5% vaginal
cancer. Mini-mental status exam scores were high for all
patients (range 27–30) and no patients were excluded
based on this exam.
Mean scores for both physicians and nurses regarding
quality of care and satisfaction with care received were
high (Table 2). There were no differences in scores
between providers (MD versus RN). Thirty-three patients
completed both QUEST surveys. Mean scores on surveys
were compared and there were no differences between
scores on the first and second survey. In addition, correla-
tion coefficients were high (Table 3). Percent agreement
between surveys for individual questions was calculated.
With the exception of question #2 (provider arriving late
for appointment), agreement between answers obtained
on both occasions was high (Table 4).
Thirteen patients (33%) had an anxiety score greater than
8 and 5 patients (13%) had a depression score of 8 or
higher. Anxiety and depression were highly correlated
with each other (r = 0.711, p < 0.01). Patients with
increased scores were referred to a psychologist within our
department for possible treatment.
Symptom severity data, available only for ovarian cancer
patients (n = 31), were used to examine patterns and rela-
tionships with satisfaction (Table 5). There was no corre-
lation between quality of care and satisfaction scores on
the QUEST with symptom severity (r = 0.085 and r =
0.009 respectively). Weakness was the most common
symptom reported, and 10 patients (32%) reported no
symptoms whatsoever. Symptom severity was correlated
with depression (r = 0.577, p = 0.001), but not anxiety.
Prior number of chemotherapy regimens or time since
diagnosis was not correlated with overall symptom sever-
ity score. When patients were stratified based on number
of prior chemotherapy regimens, there was a trend
towards more frequent reports of pain in patients who
had undergone more chemotherapy regimens. Five out of
the nine patients (55%) who had undergone three or
more chemotherapy regimens reported pain, compared to
four out of the 18 patients (22%) with one or two regi-
mens (p = 0.075).
Nineteen patients have died since the study began, all of
whom were enrolled during the years 2003–2004. There
was no difference in symptom severity score at enrollment
between patients who have died versus those still alive.
Discussion
In this prospective, observational study there was no cor-
relation between perceptions of quality and satisfaction
with care and symptom severity. Clinical variables, such
as prior number of chemotherapy regimens or time since
diagnosis, also were not related to the symptom severity
score. There was a trend towards a larger proportion of
patients who had multiple prior chemotherapy regimens
reporting pain. Weakness was the most common symp-
tom reported. Anxiety and depression were correlated
with each other and symptom severity was correlated with
depression. We also found the QUEST Survey to have test-
retest reliability when used as a written instrument in an
outpatient setting.
Quality cancer care includes provision of the most effec-
tive curative therapies, as well as excellent symptom man-
agement and sensitive end-of-life care. Symptom
management, the core of palliative care, is an integral part
of cancer care throughout the disease trajectory, while
"end-of-life" care usually refers to care during the terminal
phase or last few weeks or months of life. There is no
objective dividing line between palliative care and end-of-
life care and we use the terms interchangeably [6] in this
paper to differentiate them from curative aspects of care.
In that the majority of patients in our sample had ovarian
cancer, which typically recurs after an initial remission,Health and Quality of Life Outcomes 2006, 4:84 http://www.hqlo.com/content/4/1/84
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goals of palliative therapy include both prolonging sur-
vival as well as maintaining or improving quality of life.
Weakness and fatigue are problematic in women with
gynecologic cancer, especially ovarian cancer patients
who receive multiple chemotherapy regimens. In an inter-
esting research design, Ferrell et al. abstracted data from
"Conversations!", a newsletter for those with ovarian can-
cer in which patients publish their commentary [6]. Data
were abstracted from personal stationery, greeting cards,
and e-mail. In the pre-diagnostic complaints, fatigue was
secondary only to bloating/abdominal swelling. Sun et al.
assessed 70 patients with ovarian cancer undergoing
chemotherapy for primary or recurrent disease [7]. While
nausea and vomiting were the most problematic, fatigue
also was a significant problem and higher levels of distress
were associated with recurrent disease. These data suggest
that there may be a predictable progression of symptoms
from the initial abdominal discomfort to progressive
weakness and fatigue. Thus it may be helpful for clinicians
to specifically assess for these symptoms and prepare
patients for their occurrence.
The QUEST survey focuses on the patient's perception of
provider's time, access, and communication. In our study
scores were consistently high and there were no differ-
ences between nurses and doctors as health care provid-
ers. Patients were seen in the oncology clinic office usually
by the same gynecologic oncologist and chemotherapy
nurse specialist. Patients were assured that their responses
to questionnaires would be kept anonymous. It is possi-
ble, however, that patients may have provided answers
that they felt their health care provider expected to hear
and did not feel as if they could express negative feelings.
Sulmasey et al revealed differences with this survey
between physicians and nurses. However, this instrument
may not be sensitive enough to detect variations in clinics
where patients receive consistent care from the same
attending physicians and nurses [3]. It is also possible that
this questionnaire is not sensitive enough to pick up small
fluctuations in care.
This study revealed no correlation between satisfaction
with care and symptom severity. This may be a function of
the limited variance in the quality of satisfaction meas-
ures. However, it also may suggest that patient evaluation
of care is related more to the interpersonal aspects (trust,
caring) of the physician-patient or nurse-patient relation-
ship than it is to physical symptoms. If the patient feels
confident in the health care providers and perceives them
to be sincerely concerned, even if the symptom manage-
ment is not completely effective, the patient remains sat-
isfied. This reinforces the importance of providers
focusing on interpersonal communication, as well as pro-
vision of technically competent care, to improve satisfac-
tion with care.
Weaknesses of the study include the limited sensitivity of
the QUEST survey with this population of patients.
Table 1: Patient demographic and clinical characteristics (n = 39)
Age, mean (SD) 60.33 (10.1) years
Marital status
Married 27 (69%)
Widowed 6 (15%)
Single 4 (10%)
Unknown 2 (5%)
Race
Caucasian 32 (82%)
African-American 4 (10%)
Other 3 (7%)
Education
< HS grad 2 (5%)
HS grad 15 (38%)
Some college 12 (31%)
College grad or higher 10 (26%)
Cancer type
Ovarian/peritoneal 31 (79%)
Endometrial 7 (18%)
Vaginal 1 (3%)
Time since original diagnosis, mean (SD) 9.6 (12.7) months
Number of prior chemotherapy regimens, median (range) 2 (1–8)
Table 2: Mean (SD) scores for QUEST survey (n = 39)
MD RN P value *
Quality of care 41.95 (2.75) 42.23 (5.42) 0.76
Satisfaction with care 29.03 (1.92) 29.28 (1.70) 0.49
* Student's t-test used for comparison between providersHealth and Quality of Life Outcomes 2006, 4:84 http://www.hqlo.com/content/4/1/84
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Because of the multidimensional nature of quality of care,
a single measure cannot provide a complete assessment of
impact. Recent instruments to evaluate symptom severity
and satisfaction with care have been developed and may
be more appropriate for use in future studies [14,15].
Other options in quality of life (QOL) measures could
include FACIT-Pal for palliative care [16], FACIT-TS-PS for
treatment satisfaction [16], and possibly the Missoula-
VITAS QOL index designed to measure QOL of patients
with advance incurable diseases, weighing each dimen-
sion according to patient-reported importance [17]. An
additional limitation was the brief measure of fatigue,
which was the major symptom in this population. A
detailed fatigue measure such as the FACIT-F should be
administered to expand on the symptom evaluation for
further interventions [16]. Many of the above tools were
unavailable at the beginning of this study in 2003. Future
directions include an ongoing intervention trial targeting
symptom improvement in ovarian cancer patients during
palliative chemotherapy.
Conclusion
The QUEST Survey does demonstrate adequate test-retest
reliability when used as a written instrument in an outpa-
tient setting with gynecologic oncology patients. High sat-
isfaction and quality of care scores were obtained;
however, it may be that a variety of research instruments
should be used to evaluate this health care domain. In this
pilot investigation of women receiving palliative chemo-
therapy the most common symptom was weakness. In
addition, anxiety and/or depression were observed in over
a third of patients in this study population. As patients'
cancer progresses despite chemotherapy, they should be
frequently assessed and offered interventions for cancer
symptoms.
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Table 5: Frequency and severity of symptoms reported by 
ovarian cancer patients (n = 31)
Symptom No (%)
Weakness 14 (45%)
Mild 11
Moderate 3
Pain 9 (29%)
Mild 9
Drowsiness 9 (29%)
Mild 8
Moderate 1
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Mild 5
Moderate 1
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Mild 6